Chester Li resumes & CV records
Resumes
Chester Li
Chester Li
Chester Li
Location:
United States
Chester Li11 Fernwood Rd, Acton, MA 01720
Chester Li Phones & Addresses
11 Fernwood Rd, Acton, MA 01720 978-2644917
Ithaca, NY
26 Grasshopper Ln, Acton, MA 01720
Work
Position:
Protective Service Occupations
Education
Degree:
Graduate or professional degree
Mentions for Chester Li
Publications & IP owners
Us Patents
Genetic Modification Of The Lung As A Portal For Gene Delivery
US Patent:
2001003, Nov 1, 2001
Filed:
Feb 15, 2001
Appl. No.:
09/784563
Inventors:
Chester Li - Acton MA, US
Robin Ziegler - Sterling MA, US
Seng Cheng - Wellesley MA, US
Nelsom Yew - West Upton MA, US
Robin Ziegler - Sterling MA, US
Seng Cheng - Wellesley MA, US
Nelsom Yew - West Upton MA, US
International Classification:
A61K048/00
A61L009/04
A61K009/00
A61L009/04
A61K009/00
US Classification:
424/093210, 514/044000, 424/043000
Abstract:
The present invention relates to methods for treatment of systemic disorders using the lung as a depot organ for transgene delivery. Transfection of the pulmonary epithelium, particularly the deep alveolar cells, or pulmonary endothelial cells, is achieved via local administration of a transgene delivery vector to the lung. The transfected cells express the transgene, and the protein thereby expressed is communicated into the circulatory system. Once entering into the circulatory system, the protein is able to achieve a systemic therapeutic effect.
Genetic Modification Of The Lung As A Portal For Gene Delivery
US Patent:
2004011, Jun 10, 2004
Filed:
Aug 1, 2003
Appl. No.:
10/632302
Inventors:
Chester Li - Acton MA, US
Robin Ziegler - Westford MA, US
Seng Cheng - Wellesley MA, US
Nelson Yew - West Upton MA, US
Robin Ziegler - Westford MA, US
Seng Cheng - Wellesley MA, US
Nelson Yew - West Upton MA, US
Assignee:
Genzyme Corporation - Cambridge MA
International Classification:
A61K048/00
US Classification:
514/044000
Abstract:
The present invention relates to methods for treatment of systemic disorders using the lung as a depot organ for transgene delivery. Transfection of the pulmonary epithelium, particularly the deep alveolar cells, or pulmonary endothelial cells, is achieved via local administration of a transgene delivery vector to the lung. The transfected cells express the transgene, and the protein thereby expressed is communicated into the circulatory system. Once entering into the circulatory system, the protein is able to achieve a systemic therapeutic effect.
Genetic Modification Of The Lung As A Portal For Gene Delivery
US Patent:
2007023, Oct 11, 2007
Filed:
May 16, 2007
Appl. No.:
11/803944
Inventors:
Chester Li - Acton MA, US
Robin Ziegler - Westford MA, US
Seng Cheng - Wellesley MA, US
Nelson Yew - West Upton MA, US
Robin Ziegler - Westford MA, US
Seng Cheng - Wellesley MA, US
Nelson Yew - West Upton MA, US
Assignee:
Genzyme Corporation - Framingham MA
International Classification:
A61K 31/7088
US Classification:
514044000
Abstract:
The present invention relates to methods for treatment of systemic disorders using the lung as a depot organ for transgene delivery. Transfection of the pulmonary epithelium, particularly the deep alveolar cells, or pulmonary endothelial cells, is achieved via local administration of a transgene delivery vector to the lung. The transfected cells express the transgene, and the protein thereby expressed is communicated into the circulatory system. Once entering into the circulatory system, the protein is able to achieve a systemic therapeutic effect.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.